To assist in this effort, our office has contracted with Milliman, Inc. and the Washington State Institute for Public Policy (WSIPP).

Milliman, Inc. will conduct an analysis to evaluate how often services are used and the costs associated with each of the following services:

  • Intensive health, behavioral, and lifestyle treatment
  • Metabolic and bariatric surgery
  • Food and Drug Administration-approved obesity medication

WSIPP will analyze and evaluate the effects of identified weight-loss treatments on obesity, weight loss, and/or diabetes, and will use WSIPP's benefit-cost model to monetize effect sizes.

Given the complexity and clinical issues related to a potential obesity treatment benefit, our office has formed the Obesity Treatment Analysis Advisory Group. Members of the advisory group have experience and expertise that will help inform our work.

Advisory group meetings

July 24, 2026

July 10, 2026

April 3, 2026

Feb. 20, 2026

Jan. 23, 2026

Advisory Group Members

Name Organization
Heather Schultz Health Care Authority
John Partin Health Care Authority
Tanya Deuel Health Care Authority
Matt Prokop American Diabetes Association
Emily Brice Northwest Health Law Advocates
Erin Dziedzic/Carrie Glover Dziedzic Public Affairs
LuGina Mendez-Harper Pharmaceutical Care Management Association
Bindu Nayak Washington State Medical Association
Emily Tsiao Premera
Gregory Daniel Eli Lily and Company
Connie Miller Washington State Hospital Association
Michael Bota Washington State Hospital Association
Jenny Jackson Pharmaceutical Research and Manufacturers of America
Rick Hourigan Association of Washington Healthcare Plans
Noelle Redmond Association of Washington Healthcare Plans
Delika Steele; Jane Beyer; Rocky Patterson Project Team, Office of the Insurance Commissioner